図表

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Application
1.2.2. Source
1.2.3. Type
1.2.4. Regional scope
1.2.5. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.8. List of Secondary Source
1.9. List of Primary Source
1.10. Objectives

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Application outlook
2.2.2. Source outlook
2.2.3. Type outlook
2.2.4. Regional outlook
2.3. Competitive Insights

Chapter 3. Antithrombin Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. Antithrombin Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape

Chapter 4. Antithrombin Market: Application Estimates & Trend Analysis
4.1. Application Segment Dashboard
4.2. Antithrombin Market: Application Movement Analysis
4.3. Global Antithrombin Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
4.3.1. Therapeutics
4.3.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.3.2. Diagnostics
4.3.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.3.3. Research
4.3.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.3.4. Other
4.3.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. Antithrombin Market: Source Estimates & Trend Analysis
5.1. Source Segment Dashboard
5.2. Antithrombin Market: Source Movement Analysis
5.3. Global Antithrombin Market Size & Trend Analysis, by Source, 2021 to 2033 (USD Million)
5.3.1. Human
5.3.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.3.2. Recombinant Goat Milk
5.3.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.3.3. Others
5.3.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. Antithrombin Market: Type Estimates & Trend Analysis
6.1. Type Segment Dashboard
6.2. Antithrombin Market: Type Movement Analysis
6.3. Global Antithrombin Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
6.3.1. Anticoagulant
6.3.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
6.3.2. Antiplatelet
6.3.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
6.3.3. Thrombolytic Drugs
6.3.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. Antithrombin Market: Regional Estimates & Trend Analysis
7.1. Regional Market Dashboard
7.2. Regional Market Share Analysis, 2024 & 2030
7.3. Antithrombin Market by Region: Key Takeaways
7.4. North America
7.4.1. U.S.
7.4.1.1. Key country dynamics
7.4.1.2. Regulatory framework/ reimbursement structure
7.4.1.3. Competitive scenario
7.4.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
7.4.2. Canada
7.4.2.1. Key country dynamics
7.4.2.2. Regulatory framework/ reimbursement structure
7.4.2.3. Competitive scenario
7.4.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
7.4.3. Mexico
7.4.3.1. Key country dynamics
7.4.3.2. Regulatory framework/ reimbursement structure
7.4.3.3. Competitive scenario
7.4.3.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
7.5. Europe
7.5.1. UK
7.5.1.1. Key country dynamics
7.5.1.2. Regulatory framework/ reimbursement structure
7.5.1.3. Competitive scenario
7.5.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
7.5.2. Germany
7.5.2.1. Key country dynamics
7.5.2.2. Regulatory framework/ reimbursement structure
7.5.2.3. Competitive scenario
7.5.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
7.5.3. France
7.5.3.1. Key country dynamics
7.5.3.2. Regulatory framework/ reimbursement structure
7.5.3.3. Competitive scenario
7.5.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
7.5.4. Italy
7.5.4.1. Key country dynamics
7.5.4.2. Regulatory framework/ reimbursement structure
7.5.4.3. Competitive scenario
7.5.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
7.5.5. Spain
7.5.5.1. Key country dynamics
7.5.5.2. Regulatory framework/ reimbursement structure
7.5.5.3. Competitive scenario
7.5.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
7.5.6. Sweden
7.5.6.1. Key country dynamics
7.5.6.2. Regulatory framework/ reimbursement structure
7.5.6.3. Competitive scenario
7.5.6.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
7.5.7. Denmark
7.5.7.1. Key country dynamics
7.5.7.2. Regulatory framework/ reimbursement structure
7.5.7.3. Competitive scenario
7.5.7.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
7.5.8. Norway
7.5.8.1. Key country dynamics
7.5.8.2. Regulatory framework/ reimbursement structure
7.5.8.3. Competitive scenario
7.5.8.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
7.6. Asia Pacific
7.6.1. China
7.6.1.1. Key country dynamics
7.6.1.2. Regulatory framework/ reimbursement structure
7.6.1.3. Competitive scenario
7.6.1.4. China market estimates and forecasts 2021 to 2033 (USD Million)
7.6.2. India
7.6.2.1. Key country dynamics
7.6.2.2. Regulatory framework/ reimbursement structure
7.6.2.3. Competitive scenario
7.6.2.4. India market estimates and forecasts 2021 to 2033 (USD Million)
7.6.3. Japan
7.6.3.1. Key country dynamics
7.6.3.2. Regulatory framework/ reimbursement structure
7.6.3.3. Competitive scenario
7.6.3.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
7.6.4. Australia
7.6.4.1. Key country dynamics
7.6.4.2. Regulatory framework/ reimbursement structure
7.6.4.3. Competitive scenario
7.6.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
7.6.5. South Korea
7.6.5.1. Key country dynamics
7.6.5.2. Regulatory framework/ reimbursement structure
7.6.5.3. Competitive scenario
7.6.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
7.6.6. Thailand
7.6.6.1. Key country dynamics
7.6.6.2. Regulatory framework/ reimbursement structure
7.6.6.3. Competitive scenario
7.6.6.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
7.7. Latin America
7.7.1. Brazil
7.7.1.1. Key country dynamics
7.7.1.2. Regulatory framework/ reimbursement structure
7.7.1.3. Competitive scenario
7.7.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
7.7.2. Argentina
7.7.2.1. Key country dynamics
7.7.2.2. Regulatory framework/ reimbursement structure
7.7.2.3. Competitive scenario
7.7.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
7.8. MEA
7.8.1. South Africa
7.8.1.1. Key country dynamics
7.8.1.2. Regulatory framework/ reimbursement structure
7.8.1.3. Competitive scenario
7.8.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
7.8.2. Saudi Arabia
7.8.2.1. Key country dynamics
7.8.2.2. Regulatory framework/ reimbursement structure
7.8.2.3. Competitive scenario
7.8.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
7.8.3. UAE
7.8.3.1. Key country dynamics
7.8.3.2. Regulatory framework/ reimbursement structure
7.8.3.3. Competitive scenario
7.8.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
7.8.4. Kuwait
7.8.4.1. Key country dynamics
7.8.4.2. Regulatory framework/ reimbursement structure
7.8.4.3. Competitive scenario
7.8.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.3. Vendor Landscape
8.3.1. Key company heat map analysis, 2024
8.4. Company Profiles
8.4.1. CSL
8.4.1.1. Company overview
8.4.1.2. Financial performance
8.4.1.3. Product benchmarking
8.4.1.4. Strategic initiatives
8.4.2. Grifols, S.A.
8.4.2.1. Company overview
8.4.2.2. Financial performance
8.4.2.3. Product benchmarking
8.4.2.4. Strategic initiatives
8.4.3. Takeda Pharmaceutical Company Limited.
8.4.3.1. Company overview
8.4.3.2. Financial performance
8.4.3.3. Product benchmarking
8.4.3.4. Strategic initiatives
8.4.4. Octapharma AG
8.4.4.1. Company overview
8.4.4.2. Financial performance
8.4.4.3. Product benchmarking
8.4.4.4. Strategic initiatives
8.4.5. LFB
8.4.5.1. Company overview
8.4.5.2. Financial performance
8.4.5.3. Product benchmarking
8.4.5.4. Strategic initiatives
8.4.6. ENDPOINT HEALTH, INC.
8.4.6.1. Company overview
8.4.6.2. Financial performance
8.4.6.3. Product benchmarking
8.4.6.4. Strategic initiatives
8.4.7. Siemens Healthineers AG
8.4.7.1. Company overview
8.4.7.2. Financial performance
8.4.7.3. Product benchmarking
8.4.7.4. Strategic initiatives
8.4.8. Thermo Fisher Scientific Inc.
8.4.8.1. Company overview
8.4.8.2. Financial performance
8.4.8.3. Product benchmarking
8.4.8.4. Strategic initiatives
8.4.9. Medix Biochemica
8.4.9.1. Company overview
8.4.9.2. Financial performance
8.4.9.3. Product benchmarking
8.4.9.4. Strategic initiatives

List of Tables
Table 1 List of abbreviations
Table 2 Global antithrombin market, by region, 2021 - 2033 (USD Million)
Table 3 Global antithrombin market, by application, 2021 - 2033 (USD Million)
Table 4 Global antithrombin market, by source, 2021 - 2033 (USD Million)
Table 5 Global antithrombin market, by type, 2021 - 2033 (USD Million)
Table 6 North America antithrombin market, by country, 2021 - 2033 (USD Million)
Table 7 North America antithrombin market, by application, 2021 - 2033 (USD Million)
Table 8 North America antithrombin market, by sources, 2021 - 2033 (USD Million)
Table 9 North America antithrombin market, by type, 2021 - 2033 (USD Million)
Table 10 U.S. antithrombin market, by application, 2021 - 2033 (USD Million)
Table 11 U.S. antithrombin market, by source, 2021 - 2033 (USD Million)
Table 12 U.S. antithrombin market, by type, 2021 - 2033 (USD Million)
Table 13 Canada antithrombin market, by application, 2021 - 2033 (USD Million)
Table 14 Canada antithrombin market, by source, 2021 - 2033 (USD Million)
Table 15 Canada antithrombin market, by type, 2021 - 2033 (USD Million)
Table 16 Mexico antithrombin market, by application, 2021 - 2033 (USD Million)
Table 17 Mexico antithrombin market, by source, 2021 - 2033 (USD Million)
Table 18 Mexico antithrombin market, by type, 2021 - 2033 (USD Million)
Table 19 Europe antithrombin market, by country, 2021 - 2033 (USD Million)
Table 20 Europe antithrombin market, by application, 2021 - 2033 (USD Million)
Table 21 Europe antithrombin market, by source, 2021 - 2033 (USD Million)
Table 22 Europe antithrombin market, by type, 2021 - 2033 (USD Million)
Table 23 Germany antithrombin market, by application, 2021 - 2033 (USD Million)
Table 24 Germany antithrombin market, by source, 2021 - 2033 (USD Million)
Table 25 Germany antithrombin market, by type, 2021 - 2033 (USD Million)
Table 26 UK antithrombin market, by application, 2021 - 2033 (USD Million)
Table 27 UK antithrombin market, by source, 2021 - 2033 (USD Million)
Table 28 UK antithrombin market, by type, 2021 - 2033 (USD Million)
Table 29 France antithrombin market, by application, 2021 - 2033 (USD Million)
Table 30 France antithrombin market, by source, 2021 - 2033 (USD Million)
Table 31 France antithrombin market, by type, 2021 - 2033 (USD Million)
Table 32 Italy antithrombin market, by application, 2021 - 2033 (USD Million)
Table 33 Italy antithrombin market, by source, 2021 - 2033 (USD Million)
Table 34 Italy antithrombin market, by type, 2021 - 2033 (USD Million)
Table 35 Spain antithrombin market, by application, 2021 - 2033 (USD Million)
Table 36 Spain antithrombin market, by source, 2021 - 2033 (USD Million)
Table 37 Spain antithrombin market, by type, 2021 - 2033 (USD Million)
Table 38 Sweden antithrombin market, by application, 2021 - 2033 (USD Million)
Table 39 Sweden antithrombin market, by source, 2021 - 2033 (USD Million)
Table 40 Sweden antithrombin market, by type, 2021 - 2033 (USD Million)
Table 41 Denmark antithrombin market, by application, 2021 - 2033 (USD Million)
Table 42 Denmark antithrombin market, by source, 2021 - 2033 (USD Million)
Table 43 Denmark antithrombin market, by type, 2021 - 2033 (USD Million)
Table 44 Norway antithrombin market, by application, 2021 - 2033 (USD Million)
Table 45 Norway antithrombin market, by source, 2021 - 2033 (USD Million)
Table 46 Norway antithrombin market, by type, 2021 - 2033 (USD Million)
Table 47 Asia Pacific antithrombin market, by country, 2021 - 2033 (USD Million)
Table 48 Asia Pacific antithrombin market, by application, 2021 - 2033 (USD Million)
Table 49 Asia Pacific antithrombin market, by source, 2021 - 2033 (USD Million)
Table 50 Asia Pacific antithrombin market, by type, 2021 - 2033 (USD Million)
Table 51 China antithrombin market, by application, 2021 - 2033 (USD Million)
Table 52 China antithrombin market, by source, 2021 - 2033 (USD Million)
Table 53 China antithrombin market, by type, 2021 - 2033 (USD Million)
Table 54 India antithrombin market, by application, 2021 - 2033 (USD Million)
Table 55 India antithrombin market, by source, 2021 - 2033 (USD Million)
Table 56 India antithrombin market, by type, 2021 - 2033 (USD Million)
Table 57 Japan antithrombin market, by application, 2021 - 2033 (USD Million)
Table 58 Japan antithrombin market, by source, 2021 - 2033 (USD Million)
Table 59 Japan antithrombin market, by type, 2021 - 2033 (USD Million)
Table 60 Australia antithrombin market, by application, 2021 - 2033 (USD Million)
Table 61 Australia antithrombin market, by source, 2021 - 2033 (USD Million)
Table 62 Australia antithrombin market, by type, 2021 - 2033 (USD Million)
Table 63 South Korea antithrombin market, by application, 2021 - 2033 (USD Million)
Table 64 South Korea antithrombin market, by source, 2021 - 2033 (USD Million)
Table 65 South Korea antithrombin market, by type, 2021 - 2033 (USD Million)
Table 66 Thailand antithrombin market, by application, 2021 - 2033 (USD Million)
Table 67 Thailand antithrombin market, by source, 2021 - 2033 (USD Million)
Table 68 Thailand antithrombin market, by type, 2021 - 2033 (USD Million)
Table 69 Latin America antithrombin market, by country, 2021 - 2033 (USD Million)
Table 70 Latin America antithrombin market, by application, 2021 - 2033 (USD Million)
Table 71 Latin America antithrombin market, by source, 2021 - 2033 (USD Million)
Table 72 Latin America antithrombin market, by type, 2021 - 2033 (USD Million)
Table 73 Brazil antithrombin market, by application, 2021 - 2033 (USD Million)
Table 74 Brazil antithrombin market, by source, 2021 - 2033 (USD Million)
Table 75 Brazil antithrombin market, by type, 2021 - 2033 (USD Million)
Table 76 Argentina antithrombin market, by application, 2021 - 2033 (USD Million)
Table 77 Argentina antithrombin market, by source, 2021 - 2033 (USD Million)
Table 78 Argentina antithrombin market, by type, 2021 - 2033 (USD Million)
Table 79 Middle East & Africa antithrombin market, by country, 2021 - 2033 (USD Million)
Table 80 Middle East & Africa antithrombin market, by application, 2021 - 2033 (USD Million)
Table 81 Middle East & Africa antithrombin market, by source, 2021 - 2033 (USD Million)
Table 82 Middle East & Africa antithrombin market, by type, 2021 - 2033 (USD Million)
Table 83 South Africa antithrombin market, by application, 2021 - 2033 (USD Million)
Table 84 South Africa antithrombin market, by source, 2021 - 2033 (USD Million)
Table 85 South Africa antithrombin market, by type, 2021 - 2033 (USD Million)
Table 86 Saudi Arabia antithrombin market, by application, 2021 - 2033 (USD Million)
Table 87 Saudi Arabia antithrombin market, by source, 2021 - 2033 (USD Million)
Table 88 Saudi Arabia antithrombin market, by type, 2021 - 2033 (USD Million)
Table 89 UAE antithrombin market, by application, 2021 - 2033 (USD Million)
Table 90 UAE antithrombin market, by source, 2021 - 2033 (USD Million)
Table 91 UAE antithrombin market, by type, 2021 - 2033 (USD Million)
Table 92 Kuwait antithrombin market, by application, 2021 - 2033 (USD Million)
Table 93 Kuwait antithrombin market, by source, 2021 - 2033 (USD Million)
Table 94 Kuwait antithrombin market, by type, 2021 - 2033 (USD Million)

List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 Market formulation & validation
Fig. 7 Market snapshot
Fig. 8 Antithrombin market segmentation
Fig. 9 Market Snapshot
Fig. 10 Therapeutic approach and disease outlook (USD Million)
Fig. 11 Competitive landscape
Fig. 12 Antithrombin market dynamics
Fig. 13 Antithrombin market: Porter’s five forces analysis
Fig. 14 Antithrombin market: PESTLE analysis
Fig. 15 Application market, 2021 - 2033 (USD Million)
Fig. 16 Therapeutics market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 17 Diagnostic market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 18 Research market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 19 Other market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 20 Source market, 2021 - 2033 (USD Million)
Fig. 21 Human market estimates and forecast, 2021 - 2033
Fig. 22 Recombinant goat milk market estimates and forecast, 2021 - 2033
Fig. 23 Others market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 24 Type market, 2021 - 2033 (USD Million)
Fig. 25 Anticoagulant market, 2021 - 2033 (USD Million)
Fig. 26 Antiplatelet market, 2021 - 2033 (USD Million)
Fig. 27 Thrombolytic drugs market, 2021 - 2033 (USD Million)
Fig. 28 Antithrombin market revenue, by region
Fig. 29 Regional marketplace: Key takeaways
Fig. 30 North America antithrombin market, 2021 - 2033 (USD Million)
Fig. 31 U.S. country dynamics
Fig. 32 U.S. antithrombin market, 2021 - 2033 (USD Million)
Fig. 33 Canada country dynamics
Fig. 34 Canada antithrombin market, 2021 - 2033 (USD Million)
Fig. 35 Mexico country dynamics
Fig. 36 Mexico antithrombin market, 2021 - 2033 (USD Million)
Fig. 37 Europe antithrombin market, 2021 - 2033 (USD Million)
Fig. 38 UK country dynamics
Fig. 39 UK antithrombin market, 2021 - 2033 (USD Million)
Fig. 40 Germany country dynamics
Fig. 41 Germany antithrombin market, 2021 - 2033 (USD Million)
Fig. 42 France country dynamics
Fig. 43 France antithrombin market, 2021 - 2033 (USD Million)
Fig. 44 Italy country dynamics
Fig. 45 Italy antithrombin market, 2021 - 2033 (USD Million)
Fig. 46 Spain country dynamics
Fig. 47 Spain antithrombin market, 2021 - 2033 (USD Million)
Fig. 48 Sweden country dynamics
Fig. 49 Sweden antithrombin market, 2021 - 2033 (USD Million)
Fig. 50 Denmark country dynamics
Fig. 51 Denmark antithrombin market, 2021 - 2033 (USD Million)
Fig. 52 Norway country dynamics
Fig. 53 Norway antithrombin market, 2021 - 2033 (USD Million)
Fig. 54 Asia Pacific antithrombin market, 2021 - 2033 (USD Million)
Fig. 55 China country dynamics
Fig. 56 China antithrombin market, 2021 - 2033 (USD Million)
Fig. 57 India country dynamics
Fig. 58 India antithrombin market, 2021 - 2033 (USD Million)
Fig. 59 Japan country dynamics
Fig. 60 Japan antithrombin market, 2021 - 2033 (USD Million)
Fig. 61 Australia country dynamics
Fig. 62 Australia antithrombin market, 2021 - 2033 (USD Million)
Fig. 63 South Korea country dynamics
Fig. 64 South Korea antithrombin market, 2021 - 2033 (USD Million)
Fig. 65 Thailand country dynamics
Fig. 66 Thailand antithrombin market, 2021 - 2033 (USD Million)
Fig. 67 Latin America antithrombin market, 2021 - 2033 (USD Million)
Fig. 68 Brazil country dynamics
Fig. 69 Brazil antithrombin market, 2021 - 2033 (USD Million)
Fig. 70 Argentina country dynamics
Fig. 71 Argentina antithrombin market, 2021 - 2033 (USD Million)
Fig. 72 MEA antithrombin market, 2021 - 2033 (USD Million)
Fig. 73 South Africa country dynamics
Fig. 74 South Africa antithrombin market, 2021 - 2033 (USD Million)
Fig. 75 Saudi Arabia country dynamics
Fig. 76 Saudi Arabia antithrombin market, 2021 - 2033 (USD Million)
Fig. 77 UAE country dynamics
Fig. 78 UAE antithrombin market, 2021 - 2033 (USD Million)
Fig. 79 Kuwait country dynamics
Fig. 80 Kuwait antithrombin market, 2021 - 2033 (USD Million)
Fig. 81 Company categorization
Fig. 82 Company market position analysis
Fig. 83 Strategic framework